Why AstraZeneca plc, Balfour Beatty plc and Huntsworth plc Should Beat The FTSE 100 Today

AstraZeneca plc (LON: AZN), Balfour Beatty plc (LON: BBY) and Huntsworth plc (LON: HNT) are moving up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s going to be six weeks of losses in a row for the FTSE 100 (FTSEINDICES: ^FTSE), barring any very big surprises later today. At 6,445 points the index of top UK shares is now down 107 on the week, down 375 from its recent peak of 6,820 on 30 October, and 431 points below the 13-year peak it reached in May. Further slides before the end of the year? With the mood the way it is, I wouldn’t bet against it.

But some shares are ending the year well. Here are three from the FTSE indices putting in a good day today:

AstraZeneca

AstraZeneca (LSE: AZN) (NYSE: AZN.US) shares picked up 74.5p (2.2%) this morning to 3,533p, after the drugs giant release two pieces of good news.

The US Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory Committee has recommended the diabetes treatment dapagliflozin, opining that the benefits outweigh the risks and that it has an “acceptable cardiovascular risk profile” compared to alternatives.

The second bit of news concerns lesinurad, a gout treatment, with a phase III study having identified a statistically significant success rate.

Balfour Beatty

An update on a disposal gave Balfour Beatty (LSE: BBY) a 5.7p (2.2%) boost to 268p today.

The infrastructure firm said it has completed the sale of its facilities management business to GDF Suez Energy Services, and that the proceeds will be used to reduce borrowings and to fund future investments.

The deal will net £155m pending final adjustments.

Huntsworth

Shares in PR and healthcare communications firm Huntsworth (LSE: HNT) are up around 75% over the past 12 months.

And they got a 1.25p (2%) lift in early trading today to 65p, after the firm announced that is subsidiary Atomic is to be merged with Grayling to double the latter’s size in the US.

Atomic was acquired by Huntsworth in 2011, and the two firms have apparently worked closely since.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares mentioned in this article.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »